Gregory Davault Resigns as the Chief Marketing Officer of Ekso Bionics Holdings, Inc. and from All Other Positions with the Company and its Subsidiaries
May 15, 2018 at 04:09 pm EDT
Share
Effective May 15, 2018, Gregory Davault resigned as the Chief Marketing Officer of Ekso Bionics Holdings, Inc. and from all other positions with the Company and its subsidiaries. In connection with Mr. Devault's resignation, the Company has entered into a Separation Agreement and Full Release of All Claims dated May 9, 2018 with Mr. Davault to memorialize the parties' mutual and full agreement with respect to Mr. Davault's separation.
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
Gregory Davault Resigns as the Chief Marketing Officer of Ekso Bionics Holdings, Inc. and from All Other Positions with the Company and its Subsidiaries
EKSO BIONICS HOLDINGS, INC. 
